Log In
BCIQ
Print this Print this
 

Glucophage, Metgluco, metformin (Glucophage tablets)

  Manage Alerts
Collapse Summary General Information
Company Merck KGaA
DescriptionMetformin oral agent that improves glucose tolerance
Molecular Target Unknown
Mechanism of ActionUnknown
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationDiabetes
Indication DetailsTreat Type II diabetes
Regulatory Designation
PartnerBristol-Myers Squibb Co.;
Sumitomo Dainippon Pharma Co. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

01/04/2013

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today